Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.
Saved in:
| Title: | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. |
|---|---|
| Authors: | Karnes JH; Department of Pharmacy Practice & Science, University of Arizona College of Pharmacy, Tucson, Arizona, USA.; Sarver Heart Center, University of Arizona College of Medicine, Tucson, Arizona, USA., Rettie AE; Department of Medicinal Chemistry, University of Washington School of Pharmacy, Seattle, Washington, USA., Somogyi AA; Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia., Huddart R; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Fohner AE; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Institute of Public Health Genetics, University of Washington, Seattle, Washington, USA., Formea CM; Department of Pharmacy and Intermountain Precision Genomics, Intermountain Healthcare, Salt Lake City, Utah, USA., Ta Michael Lee M; Genomic Medicine Institute, Geisinger Health System, Danville, Pennsylvania, USA., Llerena A; INUBE Extremadura University Biosanitary Research Institute and Medical School, Badajoz, Spain., Whirl-Carrillo M; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Klein TE; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.; Department of Medicine, Stanford University, Stanford, California, USA., Phillips EJ; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Mintzer S; Department of Neurology, Thomas Jefferson University Hospital Methodist Hospital Division of Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Gaedigk A; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Caudle KE; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Callaghan JT; Department of Veteran Affairs and Departments of Medicine and Pharmacology/Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Feb; Vol. 109 (2), pp. 302-309. Date of Electronic Publication: 2020 Sep 06. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Practice Guideline |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32779747 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Karnes+JH%22">Karnes JH</searchLink>; Department of Pharmacy Practice & Science, University of Arizona College of Pharmacy, Tucson, Arizona, USA.; Sarver Heart Center, University of Arizona College of Medicine, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Rettie+AE%22">Rettie AE</searchLink>; Department of Medicinal Chemistry, University of Washington School of Pharmacy, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Somogyi+AA%22">Somogyi AA</searchLink>; Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Huddart+R%22">Huddart R</searchLink>; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Fohner+AE%22">Fohner AE</searchLink>; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Institute of Public Health Genetics, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Formea+CM%22">Formea CM</searchLink>; Department of Pharmacy and Intermountain Precision Genomics, Intermountain Healthcare, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Ta+Michael+Lee+M%22">Ta Michael Lee M</searchLink>; Genomic Medicine Institute, Geisinger Health System, Danville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Llerena+A%22">Llerena A</searchLink>; INUBE Extremadura University Biosanitary Research Institute and Medical School, Badajoz, Spain.<br /><searchLink fieldCode="AU" term="%22Whirl-Carrillo+M%22">Whirl-Carrillo M</searchLink>; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Klein+TE%22">Klein TE</searchLink>; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.; Department of Medicine, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Phillips+EJ%22">Phillips EJ</searchLink>; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Mintzer+S%22">Mintzer S</searchLink>; Department of Neurology, Thomas Jefferson University Hospital Methodist Hospital Division of Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Gaedigk+A%22">Gaedigk A</searchLink>; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Caudle+KE%22">Caudle KE</searchLink>; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Callaghan+JT%22">Callaghan JT</searchLink>; Department of Veteran Affairs and Departments of Medicine and Pharmacology/Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2021 Feb; Vol. 109 (2), pp. 302-309. <i>Date of Electronic Publication: </i>2020 Sep 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Practice Guideline – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32779747 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.2008 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 302 Titles: – TitleFull: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Karnes JH – PersonEntity: Name: NameFull: Rettie AE – PersonEntity: Name: NameFull: Somogyi AA – PersonEntity: Name: NameFull: Huddart R – PersonEntity: Name: NameFull: Fohner AE – PersonEntity: Name: NameFull: Formea CM – PersonEntity: Name: NameFull: Ta Michael Lee M – PersonEntity: Name: NameFull: Llerena A – PersonEntity: Name: NameFull: Whirl-Carrillo M – PersonEntity: Name: NameFull: Klein TE – PersonEntity: Name: NameFull: Phillips EJ – PersonEntity: Name: NameFull: Mintzer S – PersonEntity: Name: NameFull: Gaedigk A – PersonEntity: Name: NameFull: Caudle KE – PersonEntity: Name: NameFull: Callaghan JT IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2021 Feb Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 109 – Type: issue Value: 2 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |